CRISPR THERAPEUTICS AG COM CHF0.03 earnings per share and revenue

0VRQ earnings per share for the last quarter are -0.44 USD whereas the estimation was -1.20 USD which accounts for 63.35% surprise. Company revenue for the same period amounts to 35.69 M USD despite the estimated figure of 8.06 M USD. Estimated earnings per share for the next quarter are -1.23 USD, and revenue is expected to reach 6.24 M USD. Also watch annual changes over time to get a bigger picture of 0VRQ earnings per share and revenue dynamics.